RMCM
Reynders McVeigh Capital Management Portfolio holdings
AUM
$1.79B
This Quarter Return
-16.22%
1 Year Return
+14.8%
3 Year Return
+52.7%
5 Year Return
+195.9%
10 Year Return
+405.81%
AUM
$1.33B
AUM Growth
+$1.33B
(-19%)
Cap. Flow
+$18.4M
Cap. Flow
% of AUM
1.38%
Top 10 Holdings %
Top 10 Hldgs %
36.19%
Holding
237
New
8
Increased
86
Reduced
88
Closed
19
Top Buys
| 1 |
Amazon
AMZN
|
$16.9M |
| 2 |
Teradyne
TER
|
$3.8M |
| 3 |
Medtronic
MDT
|
$1.76M |
| 4 |
Procter & Gamble
PG
|
$1.7M |
| 5 |
DexCom
DXCM
|
$1.47M |
Top Sells
| 1 |
Apple
AAPL
|
$8.77M |
| 2 |
PayPal
PYPL
|
$4.6M |
| 3 |
Unilever
UL
|
$3.09M |
| 4 |
Pacific Biosciences
PACB
|
$1.03M |
| 5 |
SoFi Technologies
SOFI
|
$777K |
Sector Composition
| 1 | Healthcare | 26.75% |
| 2 | Technology | 22.62% |
| 3 | Industrials | 13.8% |
| 4 | Communication Services | 10.76% |
| 5 | Consumer Discretionary | 10.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
NextEra Energy, Inc.
NEE
$148B
| $4.39M | 0.33% |
56,699
+519
| +0.9% | +$40.2K |
|
52
Eli Lilly
LLY
$657B
| $4.14M | 0.31% |
12,755
+1,018
| +9% | +$330K |
|
53
Merck
MRK
$210B
| $4.13M | 0.31% |
45,299
-1,923
| -4% | -$175K |
|
54
Church & Dwight Co
CHD
$22.7B
| $4M | 0.3% |
43,116
| – | – |
|
55
McDonald's
MCD
$224B
| $3.94M | 0.3% |
15,965
-340
| -2% | -$83.9K |
|
56
Union Pacific
UNP
$133B
| $3.62M | 0.27% |
16,969
-345
| -2% | -$73.6K |
|
57
Berkshire Hathaway Class B
BRK.B
$1.09T
| $3.58M | 0.27% |
13,101
-1,007
| -7% | -$275K |
|
58
Fiserv
FI
$75.1B
| $3.54M | 0.27% |
39,754
-40
| -0.1% | -$3.56K |
|
59
SPDR S&P 500 ETF Trust
SPY
$658B
| $2.85M | 0.21% |
7,558
+1,619
| +27% | +$611K |
|
60
Amalgamated Financial
AMAL
$870M
| $2.63M | 0.2% |
133,158
+6,350
| +5% | +$126K |
|
61
Beam Therapeutics
BEAM
$1.66B
| $2.63M | 0.2% |
67,875
-15,389
| -18% | -$596K |
|
62
Verizon
VZ
$186B
| $2.58M | 0.19% |
50,795
+2,431
| +5% | +$123K |
|
63
IBM
IBM
$227B
| $2.51M | 0.19% |
17,786
+7,823
| +79% | +$1.1M |
|
64
Oracle
ORCL
$635B
| $2.11M | 0.16% |
30,209
-153
| -0.5% | -$10.7K |
|
65
Bristol-Myers Squibb
BMY
$96B
| $2.07M | 0.16% |
26,860
+4,346
| +19% | +$335K |
|
66
Moderna
MRNA
$9.37B
| $2.06M | 0.15% |
14,449
+351
| +2% | +$50.1K |
|
|
67
DexCom
DXCM
$29.5B
| $1.97M | 0.15% |
26,388
+19,771
| +299% | +$1.47M |
|
68
Ormat Technologies
ORA
$5.56B
| $1.97M | 0.15% |
25,082
-1,720
| -6% | -$135K |
|
69
Honeywell
HON
$139B
| $1.95M | 0.15% |
11,213
+2,625
| +31% | +$456K |
|
70
3M
MMM
$82.8B
| $1.91M | 0.14% |
14,734
-985
| -6% | -$127K |
|
71
Descartes Systems
DSGX
$8.57B
| $1.85M | 0.14% |
29,795
+6,005
| +25% | +$373K |
|
72
Norfolk Southern
NSC
$62.8B
| $1.85M | 0.14% |
8,129
-10
| -0.1% | -$2.27K |
|
73
Amgen
AMGN
$155B
| $1.79M | 0.13% |
7,338
+2
| +0% | +$487 |
|
74
Pfizer
PFE
$141B
| $1.76M | 0.13% |
33,473
-3,653
| -10% | -$192K |
|
75
Vanguard Growth ETF
VUG
$185B
| $1.74M | 0.13% |
7,802
+369
| +5% | +$82.2K |
|